Effectiveness of ECA Cream on Calcifying Shoulder Tendinitis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02986035

Acronym

ECA

Enrollment

Registered

2016-12-07

Start date

2016-10-31

Completion date

2016-12-31

Last updated

2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcifying Shoulder Tendinitis

Brief summary

This pilot trail aims to assess the effectiveness of ECA cream in the treatment of calcifying shoulder tendinitis in terms of: 1. Reduction or removal of shoulder calcifications 2. Functional improvements 3. Pain improvements 10 subjects will be assessed prior and 1 and 2 months post intervention onset. The intervention will consist in the application of the ECA cream in the affected shoulder twice a day during 1 month.

Interventions

OTHERECA cream

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients \>=18 years * diagnosed of calcifying shoulder tendinitis diagnosed by a medical specialist (rehabilitation, orthopedic surgeon or rheumatologist) by x-ray * with disease evolution of more than 3 months and less than 12 months * that give their informed consent by writing

Exclusion criteria

* Previous shoulder surgery patients * Patients with shoulder affections treated with shockwaves or corticosteroid injections.

Design outcomes

Primary

Measure	Time frame	Description
Presence of shoulder calcifications	2 months	X-ray
Size of shoulder calcifications	2 months	Ultrasonography

Secondary

Measure	Time frame	Description
Shoulder functionality	1 and 2 months	Constant Scale
Shoulder pain	1 and 2 months	Pain VAS (Visual Analogue Scale )

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026